SPASBOSTON

SPASBOSTON

202206-0224 • 560 Views • Box of 03 blisters x 10 film-coated tablets.
COMPOSITION

Each film-coated tablet contains:

Active ingredient:

Phloroglucinol hydrate

80 mg

Excipients: Microcrystalline cellulose, povidone, crospovidone, magnesium stearate, hypromellose, polyethylene glycol, lake erythrosine, iron oxide red, titanium dioxide.

Symptomatic treatment of pain related to functional disorders of the digestive tract and bile ducts.

Treatment of acute spasmodic and painful manifestations of the urinary tract: renal colic.

Symptomatic treatment of painful spasmodic manifestation in gynaecology. 

Adjuvant treatment of contractions during pregnancy in combination with rest.

DOSAGE AND ADMINISTRATION

Dosage 

Adult

The usual dosage is 2 tablets per dose, three times a day, with a minimum interval of 2 hours between each dose, do not exceed 6 tablets in a 24 hour period.

The tablets may also be used to complete a course of therapy in patients who have shown improvement during initial treatment with injectable dosage form.

Pediatric 

This dosage form is not suitable for children under 6 years of age.

In children over 6 years of age, the usual dosage is 1 tablet per dose, twice a day, with a minimum interval of 2 hours between each dose, do not exceed 2 tablets in a 24 hour period.

It should be ensured that the tablets can be swallowed.

Administration 

Oral administration. This product should be swallowed with enough water.

CONTRAINDICATIONS

Hypersensitivity to the active substance or to any of the excipients.

WARNINGS AND PRECAUTIONS

The combination of phloroglucinol with major analgesics such as morphine or its derivatives should be avoided due to their spasmogenic effect.

This product contains erythrosine, it may cause allergic reactions.

PREGNANCY AND LACTATION

Pregnancy 

Studies conducted in animals have not demonstrated any teratogenic effects. In the absence of teratogenic effects in animals, malformation in humans is not expected. Substances responsible for malformations in humans have, to date, proved teratogenic in animals during correctly conducted studies in two species. 

The relatively widespread use of phloroglucinol in clinical practice has not revealed any risk of malformative effects until now. However, epidemiological studies would be necessary to confirm the absence of risk. 

Consequently, as a precaution, this medicinal product should only be used during pregnancy if necessary.

Lactation

In the absence of data, the administration of phloroglucinol is not recommended during lactation.

EFFECTS ON ABILITY TO DRIVE AND USE MACHINES

SPASBOSTON has no or negligible effect on the ability to drive and use machines.

STORAGE CONDITION

In a dry place, below 30°C, protect from light.

SHELF-LIFE 

36 months from the manufacturing date. Do not use after the expiry date.

Aluminum/PVC blister.

Box of 10 blisters x 10 film-coated tablets.

Your comment

Similar products

MOTIBOSTON
Box of 10 blisters x 10 film-coated tablets
Contact Us
BOSMOTI
Box of 30 sachets x 1.5 g
Contact Us
RABEBOSTON
Box of 02 blisters x 14 enteric-coated tablets
Contact Us
NEOTOPASE-G
Box of 10 blisters × 10 film-coated tablets.
Contact Us
ANTALOC
Box of 10 blisters x 07 enteric-coated tablets
Contact Us
NEXIPRAZ 40
Box of 02 blisters x 07 hard capsules
Contact Us
TRIMEBOSTON 300
Box of 3 of blister x 10 coated - tablets
Contact Us
BOSMECT
Box of 30 sachets × 3.8 g/sachet.
Contact Us
IMOBOSTON
Box of 10 blisters x 10 hard capsules.
Contact Us
OMERAZ 20
Box of 10 blisters x 07 capsules containing enteric coated pellets.
Contact Us
19001910
Confirm information
Please confirm that you are a pharmacist, doctor, medical specialist,... and want to learn about the product. The information described here is only to help readers better understand the product, not for advertising or treatment purposes.